| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
16,788 |
14,530 |
$1.53M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
6,940 |
6,166 |
$606K |
| 36415 |
Collection of venous blood by venipuncture |
23,584 |
14,948 |
$585K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
9,816 |
8,025 |
$515K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
27,045 |
24,018 |
$475K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
26,066 |
23,211 |
$406K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
5,966 |
687 |
$397K |
| G0378 |
Hospital observation service, per hour |
8,252 |
5,463 |
$322K |
| 70450 |
Computed tomography, head or brain; without contrast material |
3,402 |
2,824 |
$314K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,853 |
1,620 |
$300K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,330 |
1,989 |
$261K |
| G0382 |
Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
18,794 |
15,901 |
$231K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
1,921 |
360 |
$173K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
10,091 |
9,510 |
$168K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,344 |
900 |
$159K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
18,387 |
16,734 |
$153K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
5,771 |
4,440 |
$141K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
11,341 |
10,572 |
$136K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
978 |
811 |
$130K |
| 86850 |
|
4,558 |
4,016 |
$124K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
19,081 |
12,990 |
$109K |
| 86900 |
|
4,682 |
4,124 |
$102K |
| 86901 |
|
4,379 |
3,846 |
$87K |
| 71046 |
Radiologic examination, chest; 2 views |
8,217 |
6,826 |
$87K |
| 80076 |
|
6,576 |
5,437 |
$71K |
| 82962 |
|
3,542 |
2,006 |
$60K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,844 |
2,072 |
$57K |
| 87081 |
|
12,452 |
11,484 |
$56K |
| 84112 |
|
368 |
347 |
$53K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
2,200 |
1,760 |
$52K |
| 87428 |
|
3,513 |
3,343 |
$49K |
| 81003 |
|
6,397 |
5,752 |
$45K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
21,219 |
19,341 |
$45K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
2,041 |
1,836 |
$41K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,161 |
1,906 |
$41K |
| 73630 |
|
2,001 |
1,772 |
$40K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
501 |
465 |
$40K |
| 87088 |
|
6,901 |
5,911 |
$39K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,711 |
1,630 |
$39K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,018 |
937 |
$35K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,671 |
2,502 |
$34K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
790 |
742 |
$29K |
| A9270 |
Non-covered item or service |
7,445 |
2,967 |
$28K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,119 |
2,010 |
$28K |
| 73610 |
|
1,487 |
1,328 |
$27K |
| 73562 |
|
1,550 |
1,255 |
$26K |
| 87430 |
|
12,933 |
11,942 |
$24K |
| 85610 |
|
9,295 |
6,069 |
$23K |
| 73130 |
|
1,376 |
1,222 |
$23K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
6,485 |
3,230 |
$22K |
| G0381 |
Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
1,821 |
1,537 |
$21K |
| 80047 |
|
1,586 |
1,396 |
$21K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
380 |
336 |
$20K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
1,523 |
1,312 |
$19K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
10,803 |
8,536 |
$18K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
230 |
188 |
$17K |
| 76801 |
|
983 |
822 |
$17K |
| 81001 |
|
9,586 |
8,259 |
$17K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,570 |
5,167 |
$16K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,136 |
925 |
$16K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
22,490 |
16,742 |
$16K |
| 87186 |
|
3,397 |
2,865 |
$16K |
| 11043 |
|
533 |
228 |
$15K |
| 85027 |
|
3,974 |
3,094 |
$15K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
67 |
56 |
$15K |
| 81025 |
|
5,543 |
5,125 |
$14K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,080 |
891 |
$14K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
4,612 |
3,451 |
$14K |
| 97162 |
|
683 |
521 |
$13K |
| 72100 |
|
770 |
682 |
$13K |
| 82947 |
|
4,320 |
3,094 |
$13K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,634 |
2,130 |
$13K |
| 73110 |
|
894 |
790 |
$13K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,278 |
616 |
$12K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,651 |
1,206 |
$12K |
| 73030 |
|
935 |
780 |
$12K |
| 87807 |
|
2,185 |
2,068 |
$12K |
| 82731 |
|
52 |
50 |
$11K |
| C1769 |
Guide wire |
633 |
495 |
$11K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,392 |
1,863 |
$10K |
| J1756 |
Injection, iron sucrose, 1 mg |
58 |
32 |
$10K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,799 |
3,514 |
$10K |
| 71045 |
Radiologic examination, chest; single view |
5,386 |
4,296 |
$10K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
988 |
835 |
$9K |
| 84132 |
|
1,769 |
1,506 |
$9K |
| 82565 |
|
2,910 |
2,459 |
$9K |
| 85730 |
|
3,854 |
3,188 |
$9K |
| G0383 |
Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
2,073 |
1,466 |
$9K |
| J2704 |
Injection, propofol, 10 mg |
745 |
615 |
$8K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
371 |
326 |
$8K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,920 |
4,589 |
$8K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
256 |
246 |
$8K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
893 |
834 |
$8K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
433 |
347 |
$8K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,159 |
2,644 |
$7K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
161 |
98 |
$7K |
| 87040 |
|
1,012 |
794 |
$7K |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
66 |
52 |
$7K |
| 88307 |
|
72 |
61 |
$7K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,706 |
1,147 |
$7K |
| 87077 |
|
3,825 |
3,233 |
$6K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
410 |
371 |
$6K |
| 84520 |
|
2,785 |
2,358 |
$6K |
| J7050 |
Infusion, normal saline solution, 250 cc |
361 |
233 |
$6K |
| 99215 |
Prolong outpt/office vis |
337 |
327 |
$6K |
| 87210 |
|
645 |
610 |
$5K |
| 10060 |
|
41 |
39 |
$5K |
| 72040 |
|
223 |
204 |
$5K |
| 84145 |
|
547 |
454 |
$5K |
| 93970 |
|
237 |
194 |
$4K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
845 |
787 |
$4K |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
81 |
53 |
$4K |
| 82435 |
|
1,692 |
1,450 |
$4K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
421 |
358 |
$4K |
| 80061 |
Lipid panel |
1,217 |
986 |
$4K |
| 76830 |
Ultrasound, transvaginal |
477 |
441 |
$4K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
64 |
55 |
$4K |
| 80051 |
|
1,061 |
861 |
$4K |
| 76641 |
|
113 |
82 |
$4K |
| 82374 |
|
1,691 |
1,449 |
$4K |
| 84295 |
|
1,729 |
1,472 |
$4K |
| 76775 |
|
71 |
66 |
$3K |
| J1644 |
Injection, heparin sodium, per 1000 units |
155 |
123 |
$3K |
| 73080 |
|
206 |
186 |
$3K |
| 82150 |
|
757 |
646 |
$3K |
| 87486 |
|
305 |
264 |
$3K |
| 86880 |
|
14 |
12 |
$3K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
665 |
468 |
$3K |
| J3490 |
Unclassified drugs |
585 |
445 |
$3K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
305 |
264 |
$3K |
| 72131 |
|
42 |
36 |
$2K |
| 84450 |
|
612 |
538 |
$2K |
| 97161 |
|
158 |
126 |
$2K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
596 |
121 |
$2K |
| 82977 |
|
319 |
274 |
$2K |
| 82247 |
|
767 |
654 |
$2K |
| 84075 |
|
555 |
484 |
$2K |
| 71250 |
|
89 |
65 |
$2K |
| 71101 |
|
93 |
80 |
$2K |
| 84484 |
|
5,165 |
3,588 |
$2K |
| 83880 |
|
1,145 |
879 |
$2K |
| 87147 |
|
582 |
521 |
$2K |
| 86308 |
|
506 |
472 |
$2K |
| 83690 |
|
3,123 |
2,655 |
$2K |
| 82040 |
|
873 |
731 |
$2K |
| 73140 |
|
73 |
66 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,489 |
1,223 |
$2K |
| 96376 |
|
1,795 |
1,125 |
$2K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
366 |
333 |
$2K |
| 85379 |
|
449 |
390 |
$1K |
| 84703 |
|
2,932 |
2,689 |
$1K |
| 83605 |
|
2,096 |
1,681 |
$1K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
744 |
648 |
$1K |
| 84155 |
|
377 |
325 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
678 |
559 |
$1K |
| 87581 |
|
83 |
74 |
$1K |
| 87205 |
|
910 |
771 |
$1K |
| 84460 |
|
597 |
525 |
$1K |
| 90715 |
|
586 |
492 |
$1K |
| 73502 |
|
119 |
101 |
$937.76 |
| 83735 |
|
2,239 |
1,712 |
$903.00 |
| 99205 |
Prolong outpt/office vis |
72 |
70 |
$826.45 |
| 80053 |
Comprehensive metabolic panel |
303 |
253 |
$762.68 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,393 |
1,091 |
$748.97 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
544 |
536 |
$713.50 |
| 87070 |
|
374 |
305 |
$661.42 |
| 83540 |
|
549 |
396 |
$633.85 |
| 84156 |
|
40 |
30 |
$445.22 |
| 97166 |
|
75 |
60 |
$426.47 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
265 |
226 |
$371.82 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
155 |
96 |
$370.26 |
| 88304 |
|
76 |
65 |
$356.59 |
| 83550 |
|
267 |
190 |
$353.01 |
| 74018 |
|
71 |
61 |
$334.86 |
| 93880 |
|
29 |
26 |
$321.88 |
| 88342 |
|
21 |
12 |
$311.10 |
| M0239 |
Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring |
27 |
21 |
$298.39 |
| 84702 |
|
1,045 |
862 |
$279.53 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
298 |
214 |
$267.64 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,653 |
1,333 |
$225.83 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
378 |
340 |
$209.83 |
| 75574 |
|
19 |
15 |
$196.27 |
| 86140 |
|
193 |
153 |
$123.21 |
| 73590 |
|
15 |
12 |
$109.76 |
| 83615 |
|
78 |
62 |
$104.01 |
| 29125 |
|
43 |
40 |
$99.59 |
| G0384 |
Level 5 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
202 |
99 |
$98.78 |
| J1940 |
Injection, furosemide, up to 20 mg |
19 |
12 |
$62.18 |
| 82728 |
|
381 |
298 |
$35.36 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
15 |
14 |
$21.71 |
| 82310 |
|
85 |
81 |
$0.00 |
| 99199 |
Unlisted special service, procedure or report |
226 |
218 |
$0.00 |
| 84550 |
|
73 |
55 |
$0.00 |
| 82570 |
|
30 |
25 |
$0.00 |
| 69210 |
|
25 |
24 |
$0.00 |
| J7510 |
Prednisolone oral, per 5 mg |
30 |
29 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
89 |
43 |
$0.00 |
| 85384 |
|
28 |
24 |
$0.00 |
| 29515 |
|
13 |
12 |
$0.00 |
| M0247 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring |
14 |
12 |
$0.00 |
| 87075 |
|
15 |
13 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
12 |
12 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
22 |
18 |
$0.00 |
| 82077 |
|
12 |
12 |
$0.00 |
| 82550 |
|
25 |
19 |
$0.00 |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
20 |
19 |
$0.00 |